Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Lisinopril
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Chinese University of Hong Kong
Deal Size : Inapplicable
Deal Type : Inapplicable
Clinical Bioequivalence Study on Two Lisinopril Tablets 20mg Formulations
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 26, 2018
Lead Product(s) : Lisinopril
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Chinese University of Hong Kong
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Methyldopa
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Chinese University of Hong Kong
Deal Size : Inapplicable
Deal Type : Inapplicable
Clinical Bioequivalence Study on Two Methyldopa Tablet 250mg Formulations
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 06, 2017
Lead Product(s) : Methyldopa
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Chinese University of Hong Kong
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Metoprolol Tartrate
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Chinese University of Hong Kong
Deal Size : Inapplicable
Deal Type : Inapplicable
Clinical Bioequivalence Study on Two Metoprolol Tablet 100mg Formulations
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 17, 2017
Lead Product(s) : Metoprolol Tartrate
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Chinese University of Hong Kong
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Amlodipine
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Chinese University of Hong Kong
Deal Size : Inapplicable
Deal Type : Inapplicable
Clinical Bioequivalence Study on Two Amlodipine Tablet 10mg Formulations
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 14, 2016
Lead Product(s) : Amlodipine
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Chinese University of Hong Kong
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Gliclazide
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Chinese University of Hong Kong
Deal Size : Inapplicable
Deal Type : Inapplicable
Clinical Bioequivalence Study on Two Gliclazide 80mg Tablet Formulations
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 31, 2015
Lead Product(s) : Gliclazide
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Chinese University of Hong Kong
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
